Scott Oehrlein

No open positions remaining

60 year

Health Technology

Consumer Services

Health Services

Profile

Scott Oehrlein is an Independent Director at Sauvie, Inc. He was previously the Chief Operating Officer at VIVUS, Inc. from 2018 to 2019.
Prior to that, he was the Head-Primary Care Sales US at Novartis Pharmaceuticals Corp.
from 2012 to 2014 and the Vice President & Head-General Medicines Sales at Sanofi Corp.
from 2014 to 2017.
He also served as the Global Chief Operations Officer at Willow Biopharma, Inc. from 2017 to 2018.
Oehrlein received his undergraduate degree from Franklin & Marshall College.

Scott Oehrlein active positions

Companies	Position	Start

All active positions of Scott Oehrlein

Former positions of Scott Oehrlein

Companies	Position	End
VIVUS, INC.	Chief Operating Officer	2019-10-30
Willow Biopharma, Inc. Willow Biopharma, Inc. Medical/Nursing ServicesHealth Services Provides therapeutic services	Chief Operating Officer	2018-03-31
Sanofi Corp. Sanofi Corp. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi Corp. is a biopharmaceutical company dedicated to improving health outcomes through innovative medicines, vaccines, and patient-centered care. The company is based in Bridgewater, NJ. The company offers a broad portfolio including prescription medicines across therapeutic areas such as immunology, neurology, oncology, rare diseases, cardiovascular disease, diabetes, and transplant, alongside an extensive range of vaccines protecting against infectious diseases like influenza, respiratory syncytial virus (RSV), dengue, and COVID-19. Sanofi emphasizes scientific innovation with a robust R&D pipeline comprising clinical-stage projects, including advanced therapies like bispecific antibodies, gene therapies, and mRNA vaccines. The company addresses complex conditions such as chronic graft-versus-host disease in transplant patients and rare blood disorders like immune thrombocytopenia purpura, having launched therapies in these areas. Sanofi collaborates with healthcare professionals, patient communities, advocacy groups, and governments to expand access, promote holistic care, and advance science. Social impact initiatives focus on health equity, inclusion, environmental factors affecting respiratory health, and responsible business practices. Sanofi provides resources for healthcare providers and patients, including prescribing information, patient support, and educational materials, and maintains transparent communication through media channels and regular updates on financial performance, regulatory approvals, and clinical trial progress.	Corporate Officer/Principal	2017-05-31
Novartis Pharmaceuticals Corp. Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions	Corporate Officer/Principal	2014-03-31

See the detail of Scott Oehrlein's experience

Training of Scott Oehrlein

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Scott Oehrlein's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
VIVUS, Inc. VIVUS, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes next-generation therapies	Health Technology
Franklin & Marshall College Franklin & Marshall College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novartis Pharmaceuticals Corp. Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions	Health Technology
Sanofi Corp. Sanofi Corp. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi Corp. is a biopharmaceutical company dedicated to improving health outcomes through innovative medicines, vaccines, and patient-centered care. The company is based in Bridgewater, NJ. The company offers a broad portfolio including prescription medicines across therapeutic areas such as immunology, neurology, oncology, rare diseases, cardiovascular disease, diabetes, and transplant, alongside an extensive range of vaccines protecting against infectious diseases like influenza, respiratory syncytial virus (RSV), dengue, and COVID-19. Sanofi emphasizes scientific innovation with a robust R&D pipeline comprising clinical-stage projects, including advanced therapies like bispecific antibodies, gene therapies, and mRNA vaccines. The company addresses complex conditions such as chronic graft-versus-host disease in transplant patients and rare blood disorders like immune thrombocytopenia purpura, having launched therapies in these areas. Sanofi collaborates with healthcare professionals, patient communities, advocacy groups, and governments to expand access, promote holistic care, and advance science. Social impact initiatives focus on health equity, inclusion, environmental factors affecting respiratory health, and responsible business practices. Sanofi provides resources for healthcare providers and patients, including prescribing information, patient support, and educational materials, and maintains transparent communication through media channels and regular updates on financial performance, regulatory approvals, and clinical trial progress.	Health Technology
Willow Biopharma, Inc. Willow Biopharma, Inc. Medical/Nursing ServicesHealth Services Provides therapeutic services	Health Services